
SINT Stock Forecast & Price Target
SINT Analyst Ratings
Bulls say
SINTX Technologies is a biomaterials company that has shown signs of strong growth in the first quarter of 2026, with potential for further growth in the $5 billion foot and ankle market. While they face competition, they have a successful track record of implants and are exploring new uses for their innovative silicon nitride technology. With a new president and focus on commercial execution, the company has potential for high rewards in the future.
Bears say
SINTX Technologies is a commercial-stage company with a significant potential for growth in the medical device sector. However, market risks remain to be a key concern, and the company's heavy reliance on partnerships for commercial success creates uncertainty. Although the recent FDA clearance and first human implant of the SiNAPTIC Foot & Ankle system is a positive sign, it remains to be seen if SINTX can drive broader adoption and generate expected revenues. The company's current valuation is attractive, but the risks must be carefully monitored before making any investment decisions.
This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
SINT Analyst Forecast & Price Prediction
Start investing in SINT
Order type
Buy in
Order amount
Est. shares
0 shares